GENAZZANI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 63.137
AS - Asia 29.438
EU - Europa 21.597
SA - Sud America 3.282
AF - Africa 351
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 34
AN - Antartide 1
Totale 117.892
Nazione #
US - Stati Uniti d'America 61.326
CN - Cina 10.123
SG - Singapore 8.593
IT - Italia 6.467
HK - Hong Kong 4.711
SE - Svezia 3.008
BR - Brasile 2.882
KR - Corea 2.475
BG - Bulgaria 2.284
UA - Ucraina 2.164
PL - Polonia 1.826
CA - Canada 1.623
TR - Turchia 1.348
DE - Germania 1.344
VN - Vietnam 1.093
RU - Federazione Russa 962
GB - Regno Unito 887
CH - Svizzera 880
FI - Finlandia 856
FR - Francia 358
IN - India 242
JP - Giappone 150
BE - Belgio 137
AR - Argentina 131
BD - Bangladesh 124
ID - Indonesia 110
IQ - Iraq 91
MX - Messico 83
NL - Olanda 78
EC - Ecuador 75
ZA - Sudafrica 70
CI - Costa d'Avorio 56
VE - Venezuela 54
ES - Italia 50
MA - Marocco 49
PK - Pakistan 48
SA - Arabia Saudita 45
UZ - Uzbekistan 45
CO - Colombia 41
IE - Irlanda 39
AU - Australia 38
GR - Grecia 36
RO - Romania 29
BJ - Benin 28
EU - Europa 28
KE - Kenya 27
NP - Nepal 26
IL - Israele 25
UY - Uruguay 25
CL - Cile 24
JM - Giamaica 24
CZ - Repubblica Ceca 23
HU - Ungheria 23
JO - Giordania 23
AT - Austria 22
AE - Emirati Arabi Uniti 21
EG - Egitto 21
PE - Perù 21
PY - Paraguay 21
TN - Tunisia 20
PT - Portogallo 19
TT - Trinidad e Tobago 19
DK - Danimarca 17
LB - Libano 15
PH - Filippine 14
SN - Senegal 14
KZ - Kazakistan 13
MY - Malesia 13
NZ - Nuova Zelanda 13
AL - Albania 12
AZ - Azerbaigian 11
HR - Croazia 11
LT - Lituania 11
DZ - Algeria 10
NG - Nigeria 10
RS - Serbia 10
HN - Honduras 9
AO - Angola 8
BO - Bolivia 8
CR - Costa Rica 8
EE - Estonia 8
ET - Etiopia 8
OM - Oman 7
TW - Taiwan 7
BS - Bahamas 6
CY - Cipro 6
IR - Iran 6
NO - Norvegia 6
XK - ???statistics.table.value.countryCode.XK??? 6
AM - Armenia 5
BB - Barbados 5
CG - Congo 5
DO - Repubblica Dominicana 5
IS - Islanda 5
LK - Sri Lanka 5
LV - Lettonia 5
NI - Nicaragua 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
SV - El Salvador 5
Totale 117.793
Città #
Woodbridge 8.160
Ann Arbor 5.939
Ashburn 5.486
Houston 5.463
Fairfield 5.347
Singapore 4.824
Hong Kong 4.685
Chandler 3.680
Hefei 3.246
Milan 3.108
Jacksonville 2.854
Dallas 2.805
Seoul 2.451
Seattle 2.407
Sofia 2.281
Wilmington 2.026
Cambridge 1.868
Ottawa 1.497
Shanghai 1.473
New York 1.278
Beijing 1.269
Santa Clara 1.002
Nanjing 903
Boardman 891
Izmir 872
Bern 862
Princeton 849
Lawrence 841
Medford 808
Des Moines 630
The Dalles 510
Los Angeles 508
Jüchen 504
Dearborn 497
Columbus 446
Istanbul 402
Dong Ket 386
Buffalo 381
Nanchang 330
Council Bluffs 284
San Diego 236
São Paulo 214
Falls Church 212
Rome 195
Kunming 193
Shenyang 167
Redondo Beach 162
Boulder 160
Changsha 141
Hebei 137
Brussels 135
Marseille 135
Tokyo 132
Ogden 129
Tianjin 121
Lancaster 115
Norwalk 115
Ho Chi Minh City 106
Jiaxing 99
Redwood City 93
Rio de Janeiro 93
Jakarta 91
Frankfurt am Main 90
San Jose 90
Orange 86
Guangzhou 81
Belo Horizonte 76
Verona 76
Pune 73
Washington 71
Hangzhou 69
Munich 69
Florence 67
London 66
Düsseldorf 64
Abidjan 56
Brasília 56
Serra 53
Curitiba 52
Jinan 51
Hanoi 48
Fuzhou 45
Lanzhou 45
San Francisco 42
Baghdad 41
Edinburgh 41
Tashkent 40
Campinas 39
Phoenix 39
Changchun 38
Chicago 38
Indiana 38
Zhengzhou 38
Warsaw 37
Dhaka 32
Boston 31
Fortaleza 31
Porto Alegre 31
Detroit 30
Toronto 30
Totale 89.234
Nome #
Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism 1.961
Neuroendocrine Changes during Menopausal Transition 588
Menopause, Hormone Replacement Therapy (HRT) and Obesity 421
Optimizing quality of life through sex steroids by their effects on neurotransmitters 340
Dermorphin decreases plasma LH levels in human: evidence for a modulatory role of gonadal steroids. 241
Plasma levels of gonadotropins, prolactin, thyroxine, and adrenal and gonadal steroids in obese prepubertal girls. 238
Plasma and CSF endorphin levels in primary and symptomatic headaches. 236
Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery 234
Clinical and endocrinological investigations on superovulation induced in heifers by human menopausal gonadotrophin. 229
Oral dehydroepiandrosterone restores β-endorphin response to OGTT in early and late postmenopause 227
Secretion pattern of endogenous opioids in chronic schizophrenia. 225
Oestradiol/progesterone imbalance and the premenstrual syndrome. 225
Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine. 223
Reduced ACTH content in cerebrospinal fluid of children affected by cryptogenic infantile spasms with hypsarrhythmia. 219
Plasma androgens and menstrual cycle: physiopathological correlates from adolescence to menopause. 219
Domperidone in defective and insufficient lactation. 219
Estimation of instantaneous secretory rate of luteinizing hormone in women during the menstrual cycle and in men. 218
Pituitary response to hypoglycemia in pituitary diseases. 216
Plasma opioid levels in post-traumatic chronic headache and trigeminal neuralgia: maintained response to acupuncture. 216
Plasma opioids in the first hours of life. 216
Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome. 216
Doppler ultrasound studies of the uterine arteries in spontaneous and IVF stimulated ovarian cycles. 215
Opioids and testicular activity in the frog, Rana esculenta. 215
Cytogenetic study on 282 patients with suspected chromosomal aberration. 214
Endogenous opioid inhibitory tone on LH secretion in normal puberty and in several pubertal disturbances. 213
Effect of two indirectly acting dopamine agonists on prolactin secretion in normo- and hyperprolactinemic subjects: comparison with the effect of nomifensine. 212
Opioid peptides of the pituitary and hypothalamus: changes in pregnant and lactating rats. 212
Pregnancy diagnosis in cattle by a rapid and highly reliable method for progesterone determination in milk. 212
Absent B-endorphin response to clonidine in obese children. 211
Neuroendocrine effect of a short-term treatment with DHEA in postmenopausal women. 211
Pituitary proopiomelanocortin peptides in mental disorders. 208
Concomitant increase in nociceptive flexion reflex threshold and plasma opioids following transcutaneous nerve stimulation. 207
Beta-endorphin and met-enkephalin in peritoneal and ovarian follicular fluids of fertile and postmenopausal women. 207
Impairment of opioid control of luteinizing hormone secretion in menstrual disorders. 207
Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine. 207
Prolactin changes after administration of agonist and antagonist dopaminergic drugs in puerperal women. 206
Menstrual-related mood changes in patients with oligomenorrhea. 206
The association of menstrual migraine with the premenstrual syndrome. 206
Plasma thyrotrophin levels during pregnancy. 205
Gonadal steroid modulation of naloxone-induced LH secretion in the rat. 205
Reduced cerebrospinal fluid B-endorphin levels in Rett syndrome. 205
Expression of proopiomelanocortin-related peptides in human follicular fluid. 205
The relative contributions of menopause and aging to postmenopausal reduction in intervertebral disk height 205
Glucocorticoids but not vasopressin or oxytocin inhibit luteinizing hormone secretion in patients with psychogenic amenorrhea. 204
Nomifensine: diagnostic test in hyperprolactinemic states. 203
Progressive impairment of CSF beta-EP levels in migraine sufferers. 203
Presence of acetylated and shortened endorphins in human fetal pituitary gland. 203
Growth hormone treatment affects plasma LH pulsatile release in women with secondary amenorrhoea. 203
Polymorphisms of the FTO and MTHFR genes and vascular, inflammatory and metabolic marker levels in postmenopausal women 203
Fetal intermediate lobe is stimulated by parturition 202
Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels. 202
Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists. 201
Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology. 201
Endorphin patterns within the headache spectrum disorders. 201
Central opioid receptor activity in patients affected by puerperal, idiopathic and tumoral hyperprolactinemia. 201
Opioid control of luteinizing hormone secretion in patients with hirsutism and hyperandrogenemia. 201
Plasma beta-endorphin and beta-lipotropin levels increase in well trained athletes after competition and non competitive exercise. 201
Adrenal and gonadal steroids and pituitary response to LHRH in girls. II. Precocious puberty. 200
Different rebound rise in plasma prolactin during the postdopamine infusion phase in puerperal women and patients with pathological hyperprolactinemia 200
Lack of beta-endorphin plasma level rise in oxytocin-induced labor. 200
Beta-lipotropin and beta-endorphin in physiological and surgical menopause. 200
Hypothalamus-pituitary-adrenal axis of heroin addicts. 200
Proopiomelanocortin-related peptides and methionine enkephalin in human follicular fluid: changes during the menstrual cycle. 200
Circulating opioids and plasma renin activity in insulin-dependent diabetics with renal haemodynamic alterations. 199
Naproxen sodium in the treatment of premenstrual symptoms. A placebo-controlled study. 199
The HRT misuse and osteoporosis epidemic: a possible future scenario 199
Adrenal and gonadal steroids in girls during sexual maturation. 198
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome 198
Circulating beta-endorphin levels at various stages of life: possible connections with migraine pathogenesis. 196
Factors associated with pain complaints in a clinical sample of postmenopausal women. 196
Contraception in older woman. 196
Opioid plasma levels during labour. 195
Reduced estriol and dehydroepiandrosterone sulphate plasma levels in methadone-addicted pregnant women. 195
Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. 195
Use of human-placental-lactogen radioimmunoassay to predict outcome in cases of threatened abortion. 194
Plasma levels of luteinizing hormone, estradiol and androstenedione in sows with inadequate plasma progesterone. 194
Response of circulating adrenocorticotropin, beta-endorphin, beta-lipotropin and cortisol to athletic competition. 194
Endothelium and estrogen receptors 194
Intrinsic secretory characteristics of luteinizing hormone and prolactin episodic release during pubertal development. 193
Effect of estetrol administration on brain and serum allopregnanolone in intact and ovariectomized rats 193
Pregnancy related changes of opiate receptors identified in rat uterine membranes by 3H-naloxone binding. 192
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea. 192
Adrenal and gonadal steroids and pituitary response to LHRH in girls. I. Delayed puberty. 191
Met-enkephalin enhances follicle-stimulating hormone-dependent progesterone production from cultured granulosa cells. 191
Human neu oncogene is expressed in endometrial but not in ovarian adenocarcinomas. 191
The study with a million women (and hopefully fewer mistakes) 191
Nomifensine-induced pregnancy in a hyperprolactinemic woman. 190
The neuroendocrine effects of sumatriptan, a specific ligand for 5-HT1-like receptors. 190
Impairment of adrenergic-induced proopiomelanocortin-related peptide release in heroin addicts. 189
Episodic release of prolactin in women with weight loss-related amenorrhea. 189
Effects of etoperidone on sympathetic and pituitary-adrenal responses to diverse stressors in humans. 189
Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel. 189
Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women 189
Impairment of the opioidergic control of luteinizing hormone secretion in Turner's syndrome: lack of effect of gonadal steroid therapy. 188
Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy Villa Tuscolana, Frascati (Rome), May 8-9, 2007 188
Neuroendocrine evaluation of central opiate activity in primary headache disorders 187
Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome 187
The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy 186
Premenstrual increase of intracellular magnesium levels in women with ovulatory, asymptomatic menstrual cycles. 185
Serum levels of dimeric activin A are not a marker of placental tumors in the course of chemotherapy. 185
Totale 22.857
Categoria #
all - tutte 292.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 292.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.120 0 0 0 0 0 245 566 694 467 638 405 1.105
2021/20228.772 72 341 137 741 1.943 1.361 180 386 623 226 304 2.458
2022/20238.366 1.193 702 344 799 1.231 1.315 100 761 1.247 46 527 101
2023/202411.138 1.944 1.174 1.512 628 1.315 1.403 106 300 176 1.867 85 628
2024/202522.240 47 921 141 1.491 1.143 1.613 1.641 1.529 2.458 3.377 3.816 4.063
2025/202616.592 2.449 4.498 4.275 1.547 1.583 2.240 0 0 0 0 0 0
Totale 118.347